Tỷ suất cổ tức của BCTXL là bao nhiêu?

Briacell Therapeutics Corp. Warrant Expiring 2031 có tỷ suất cổ tức 0.00%.

Bây giờ có nên mua cổ phiếu BCTXL không?

Điểm AI Timing của BCTXL là 1/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu BCTXL (NASDAQ) | Briacell Therapeutics Corp.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: -)

BCTXL AI Analysis Summary

Our AI summary for BCTXL: Briacell Therapeutics Corp. Warrant Expiring 2031 (NASDAQ). The stock currently trades at a P/E of 0.00, a dividend yield of 0.00%. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

BCTXL

Briacell Therapeutics Corp. Warrant Expiring 2031

US:NASDAQ STOCK News 77

USD 0.90

0.04 (4.65%) Day Change

Watchlist Portfolio Compare Chart

0.00%

Div Yield

BRIACELL THERAPEUTICS CORP. WARRANT EXPIRING 2031
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.90 Price 0.04 (4.65%) Day Change	NEWS SCORE: 77

Not enough data to analyze.

Loading chart...

N/A

QUALITY

Signal: N/A

Signal Description: N/A

Reason: N/A

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	77
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.90
PBV / Sector	0.32 / N/A GREAT
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	3863.811725000000
Average 1W Daily Value	3912.844900000000

Yếu tố Kỹ thuật

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / N/A
NPM Average (%) / Sector	N/A / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	N/A / N/A
ROA Average (%) / Sector	N/A / N/A
ROA Change Average (%) / Sector	N/A / N/A
ROE (%) / Sector	N/A / N/A
ROE Average (%) / Sector	N/A / N/A
ROE Change Average (%) / Sector	N/A / N/A
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

Chi tiết đăng ký

Analyze Date
Symbol	BCTXL
Name	BRIACELL THERAPEUTICS CORP. WARRANT EXPIRING 2031
Sector	N/A
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	7.54 / N/A

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1

Phone: 604 921 1810

Website: https://briacell.com

Employees: -

Sector: -

Description: BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.